According to recent media reports such as Asahi Shimbun, there are 621 new confirmed cases of New Coronary Pneumonia in Tokyo, and the average daily number of new confirmed cases in the recent week is 798.9, an increase of 5.3% compared with the previous week.

Shinya Yamanaka, director of the iPS Cell Research Institute at Kyoto University in Japan, who won the Nobel Prize in Physiology or Medicine in 2012, recently gave an interview on how to quell the recent New Coronary Pneumonia outbreak, saying, "It depends on whether the government can expand the scope of vaccination for the public as quickly as possible with all its might." In my opinion, in addition to vaccination against NCC, rapid Nucleic Acid Testing is also a favorable prevention and control weapon against the NCC epidemic, and maximum screening by rapid Nucleic Acid Testing can keep the NCC epidemic to a minimum!

Recently, the domestic epidemic gradually subsided, the production of new crown nucleic acid rapid test products are gradually aimed at overseas markets, in a large number of companies to enter the overseas at the same time, I think for the inspection practitioners, regardless of the amount of new crown nucleic acid rapid test, regardless of the domestic and international should bear in mind: quality is the life of the test! New crown nucleic acid rapid test product quality is about the safety of people's lives.

Domestic companies and our company Rui Kang launched the new crown nucleic acid rapid test system covers all aspects of nucleic acid testing, in the research and development stage will be the reagents and reagents, reagents and instruments match between the strict debugging, optimization of detection procedures. Whether it is a large-scale rapid sample screening or a small batch of new crown nucleic acid rapid test, the test results can ensure the true and effective.